Myopia Outcome Study of Atropine in Children (MOSAIC): an investigator-led, double-masked, placebo-controlled, randomised clinical trial protocol

Authors

Saoirse McCrann, Technological University DublinFollow
Daniel Ian Flitcroft, Technological University DublinFollow
Niall C. Strang, Glasgow Caledonian University, Glasgow, UK
Kathryn J. Saunders, University of Ulster, Coleraine, UK
Nicola S. Logan, Aston University, Birmingham, UK
Samantha Szeyee Lee, University of Western Australia, Perth, WA, Australia
David A. Mackey, University of Western Australia, Perth, WA, Australia
John Butler, TU DublinFollow
James Loughman, Technological University DublinFollow

Document Type

Article

Rights

Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence

Disciplines

Ophthalmology

Abstract

Background: The Myopia Outcome Study of Atropine in Children (MOSAIC) aims to explore the efficacy, safety, acceptability and mechanisms of action of 0.01% unpreserved atropine for myopia control in a European population. Methods: MOSAIC is an

DOI

https://doi.org/10.12688/hrbopenres.12914.1

Recommended Citation

McCrann S, Flitcroft I, Strang NC et al. Myopia Outcome Study of Atropine in Children (MOSAIC): an investigator-led, double-masked, placebo-controlled, randomised clinical trial protocol. HRB Open Res 2019, 2:15 doi:10.12688/hrbopenres.12914.1

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.